Tinea pedis (Athlete Foot) - Pipeline Review, H2 2016 - Therapeutics Assessment By Drug Target, MoA, RoA & Molecule Type - Research and Markets

DUBLIN--()--Research and Markets has announced the addition of the "Tinea pedis (Athlete Foot) - Pipeline Review, H2 2016" report to their offering.

Athlete's foot, also known as tinea pedis, is a common foot infection caused by fungi called dermatophytes. Symptoms include dry flaking skin on the soles of the feet, unpleasant foot odour and small itchy bubbles or blisters on the soles of the feet. Treatment includes antifungal medicines.

This report provides comprehensive information on the therapeutic development for Tinea pedis (Athlete Foot), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Tinea pedis (Athlete Foot) and special features on late-stage and discontinued projects.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Key Topics Covered:

  1. Introduction
  2. Tinea pedis (Athlete Foot) Overview
  3. Therapeutics Development
  4. Pipeline Products for Tinea pedis (Athlete Foot) - Overview
  5. Pipeline Products for Tinea pedis (Athlete Foot) - Comparative Analysis
  6. Tinea pedis (Athlete Foot) - Therapeutics under Development by Companies
  7. Tinea pedis (Athlete Foot) - Therapeutics under Investigation by Universities/Institutes
  8. Tinea pedis (Athlete Foot) - Pipeline Products Glance
  9. Late Stage Products
  10. Clinical Stage Products
  11. Early Stage Products
  12. Tinea pedis (Athlete Foot) - Products under Development by Companies
  13. Tinea pedis (Athlete Foot) - Products under Investigation by Universities/Institutes
  14. Tinea pedis (Athlete Foot) - Companies Involved in Therapeutics Development

Companies Mentioned:

  • Anacor Pharmaceuticals Inc
  • Astellas Pharma Inc
  • Biolab Farmaceutica Ltda
  • Blueberry Therapeutics Ltd
  • Dermala Inc
  • Helix BioMedix Inc
  • Novan Inc
  • Novoteris LLC
  • Sol-Gel Technologies Ltd
  • Viamet Pharmaceuticals Inc

For more information about this report visit http://www.researchandmarkets.com/research/xqqvj5/tinea_pedis

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T. Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Infectious Diseases Drugs, Infectious Diseases Drugs

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T. Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Infectious Diseases Drugs, Infectious Diseases Drugs